Accendra Health (ACH) Revenue & Revenue Breakdown

Overview ForecastFinancials Chart Transcripts

Accendra Health Revenue Highlights

Latest Revenue (Y)

$2.76B

Latest Revenue (Q)

$697.26M

Main Segment (Y)

Diabetes Product

Main Geography (Y)

UNITED STATES

Accendra Health Revenue by Period

Accendra Health Revenue by Year

Date	Revenue	Change
2025-12-31	$2.76B	-74.19%
2024-12-31	$10.70B	3.55%
2023-12-31	$10.33B	3.80%
2022-12-31	$9.96B	1.74%
2021-12-31	$9.79B	15.39%
2020-12-31	$8.48B	-7.93%
2019-12-31	$9.21B	-2.20%
2018-12-31	$9.42B	1.07%
2017-12-31	$9.32B	-4.17%
2016-12-31	$9.72B	-0.51%
2015-12-31	$9.77B	3.52%
2014-12-31	$9.44B	4.06%
2013-12-31	$9.07B	1.83%
2012-12-31	$8.91B	3.25%
2011-12-31	$8.63B	6.21%
2010-12-31	$8.12B	1.07%
2009-12-31	$8.04B	10.97%
2008-12-31	$7.24B	6.51%
2007-12-31	$6.80B	22.89%
2006-12-31	$5.53B	14.75%
2005-12-31	$4.82B	6.57%
2004-12-31	$4.53B	6.62%
2003-12-31	$4.24B	7.18%
2002-12-31	$3.96B	3.80%
2001-12-31	$3.81B	8.89%
2000-12-31	$3.50B	9.95%
1999-12-31	$3.19B	3.38%
1998-12-31	$3.08B	-1.11%
1997-12-31	$3.12B	3.24%
1996-12-31	$3.02B	-

Accendra Health generated $2.76B in revenue during NA 2025, up -74.19% compared to the previous quarter, and up 32.57% compared to the same period a year ago.

Accendra Health Revenue by Quarter

Date	Revenue	Change
2025-09-30	$697.26M	2.25%
2025-06-30	$681.92M	-74.09%
2025-03-31	$2.63B	-2.37%
2024-12-31	$2.70B	292.53%
2024-09-30	$686.85M	4.00%
2024-06-30	$660.40M	3.54%
2024-03-31	$637.84M	-75.99%
2023-12-31	$2.66B	2.49%
2023-09-30	$2.59B	1.11%
2023-06-30	$2.56B	1.60%
2023-03-31	$2.52B	-1.11%
2022-12-31	$2.55B	2.15%
2022-09-30	$2.50B	-0.10%
2022-06-30	$2.50B	3.87%
2022-03-31	$2.41B	-2.44%
2021-12-31	$2.47B	-1.40%
2021-09-30	$2.50B	0.51%
2021-06-30	$2.49B	7.00%
2021-03-31	$2.33B	-1.49%
2020-12-31	$2.36B	7.95%
2020-09-30	$2.19B	21.03%
2020-06-30	$1.81B	-14.84%
2020-03-31	$2.12B	-3.10%
2019-12-31	$2.19B	-4.45%
2019-09-30	$2.29B	-3.53%
2019-06-30	$2.38B	1.10%
2019-03-31	$2.35B	10.76%
2018-12-31	$2.12B	-13.89%
2018-09-30	$2.46B	0.27%
2018-06-30	$2.46B	3.61%
2018-03-31	$2.37B	-0.72%
2017-12-31	$2.39B	2.39%
2017-09-30	$2.33B	3.00%
2017-06-30	$2.27B	-2.69%
2017-03-31	$2.33B	-1.68%
2016-12-31	$2.37B	-1.96%
2016-09-30	$2.42B	-2.74%
2016-06-30	$2.48B	1.14%
2016-03-31	$2.46B	-1.29%
2015-12-31	$2.49B	0.66%
2015-09-30	$2.47B	2.04%
2015-06-30	$2.42B	1.30%
2015-03-31	$2.39B	-4.04%
2014-12-31	$2.49B	4.43%
2014-09-30	$2.39B	3.48%
2014-06-30	$2.31B	2.19%
2014-03-31	$2.26B	-2.68%
2013-12-31	$2.32B	2.11%
2013-09-30	$2.27B	0.17%
2013-06-30	$2.27B	-0.40%
2013-03-31	$2.28B	-2.12%
2012-12-31	$2.32B	6.65%
2012-09-30	$2.18B	-0.25%
2012-06-30	$2.19B	-1.46%
2012-03-31	$2.22B	1.00%
2011-12-31	$2.20B	0.88%
2011-09-30	$2.18B	2.13%
2011-06-30	$2.13B	0.36%
2011-03-31	$2.12B	2.59%
2010-12-31	$2.07B	-

Accendra Health generated $697.26M in revenue during Q3 2025, up 2.25% compared to the previous quarter, and up 105.58% compared to the same period a year ago.

Accendra Health Revenue Breakdown

Accendra Health Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Diabetes Product	$783.37M	-	-	-	-
Product and Service, Other	$288.19M	-	-	-	-
Urology	$116.02M	-	-	-	-
Wound Care	$188.51M	-	-	-	-
Patient Direct	-	$2.68B	$2.55B	$2.06B	-
Products & Healthcare Services	-	$8.02B	$7.78B	$7.90B	-
Global Products	-	-	-	-	$2.66B
Global Solutions	-	-	-	-	$7.86B

Accendra Health's latest annual revenue breakdown by segment (product or service), as of Dec 25: Diabetes Product (56.93%), Product and Service, Other (20.94%), Wound Care (13.70%), and Urology (8.43%).

Quarterly Revenue by Product

Product/Service	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
Urology	$58.35M	$28.98M	$28.70M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Product and Service, Other	$143.30M	$72.59M	$72.30M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Diabetes Product	$390.94M	$201.37M	$191.06M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Wound Care	$93.69M	$48.00M	$46.82M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Products & Healthcare Services	-	-	-	$1.96B	$2.00B	$2.03B	$2.01B	$1.97B	$3.94B	$1.93B	$1.92B	$1.93B	$1.90B	$1.93B	$2.13B	-	-	-	-	-
Patient Direct	-	-	-	$673.88M	$695.02M	$686.85M	$660.40M	$637.84M	$1.31B	$632.50M	$607.36M	$617.49M	$594.04M	$572.63M	$272.91M	-	-	-	-	-
Rental Equipment	-	-	-	-	-	-	-	-	-	$158.00M	-	-	-	-	-	-	-	-	-	-
Global Products	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$629.34M	$679.07M	$688.57M	$658.75M
Global Solutions	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$2.01B	$2.02B	$1.98B	$1.85B

Accendra Health's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Diabetes Product (56.97%), Product and Service, Other (20.88%), Wound Care (13.65%), and Urology (8.50%).

Accendra Health Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Non-US	$242.94M	$275.29M	$429.44M	$534.98M	$349.77M
UNITED STATES	$10.46B	$10.06B	$9.53B	$9.25B	$8.13B

Accendra Health's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (97.73%), and Non-US (2.27%).

Quarterly Revenue by Country

Country	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20
UNITED STATES	$2.58B	$2.64B	$2.66B	$2.61B	$2.55B	$2.59B	$2.52B	$2.50B	$2.45B	$2.48B	$2.41B	$2.38B	$2.26B	$2.35B	$2.38B	$2.34B	$2.18B	$2.26B	$2.10B	$1.74B
Non-US	$51.33M	$59.22M	$59.66M	$62.00M	$62.07M	$67.90M	$72.79M	$64.69M	$69.91M	$74.45M	$86.61M	$123.44M	$144.93M	$117.04M	$121.38M	$152.79M	$143.78M	$103.57M	$86.85M	$70.10M

Accendra Health's latest quarterly revenue breakdown by geography, as of Mar 25: UNITED STATES (98.05%), and Non-US (1.95%).

Accendra Health Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
ACH	Accendra Health	$2.76B	$697.26M
HITI	High Tide	$487.67M	$124.26M
CGC	Canopy Growth	$297.15M	$90.39M
OM	Outset Medical	$119.48M	$29.43M
SGHT	Sight Sciences	$77.36M	$19.91M
CVRX	CVRx	$56.65M	$14.69M
ACRS	Aclaris Therapeutics	$7.83M	$3.30M
EDIT	Editas Medicine	-	-
CABA	Cabaletta Bio	-	-
ALLO	Allogene Therapeutics	-	-
BIOA	BioAge Labs	-	$2.05M

ACH Revenue FAQ

What is Accendra Health’s yearly revenue?

Accendra Health's yearly revenue for 2025 was $2.76B, representing a decrease of -74.19% compared to 2024. The company's yearly revenue for 2024 was $10.7B, representing an increase of 3.55% compared to 2023. ACH's yearly revenue for 2023 was $10.33B, representing an increase of 3.80% compared to 2022.

What is Accendra Health’s quarterly revenue?

Accendra Health's quarterly revenue for Q3 2025 was $697.26M, a 2.25% increase from the previous quarter (Q2 2025), and a 1.52% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $681.92M, a -74.09% decrease from the previous quarter (Q1 2025), and a 3.26% increase year-over-year (Q2 2024). ACH's quarterly revenue for Q1 2025 was $2.63B, a -2.37% decrease from the previous quarter (Q4 2024), and a 312.65% increase year-over-year (Q1 2024).

What is Accendra Health’s revenue growth rate?

Accendra Health's revenue growth rate for the last 3 years (2023-2025) was -73.27%, and for the last 5 years (2021-2025) was -71.77%.

What are Accendra Health’s revenue streams?

Accendra Health's revenue streams in c 25 are Diabetes Product, Product and Service, Other, Urology, and Wound Care. Diabetes Product generated $783.37M in revenue, accounting 56.93% of the company's total revenue Product and Service, Other generated $288.19M in revenue, accounting 20.94% of the company's total revenue Urology generated $116.02M in revenue, accounting 8.43% of the company's total revenue Wound Care generated $188.51M in revenue, accounting 13.70% of the company's total revenue

What is Accendra Health’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Accendra Health was Diabetes Product. This segment made a revenue of $783.37M, representing 56.93% of the company's total revenue.